Sai Life Sciences Ltd (NSE:SAILIFE) (Q2 2027) Earnings Call Highlights: 23% Revenue Growth, ...
Sai Life Sciences Ltd (NSE:SAILIFE) delivered strong Q2 FY27 momentum with CRO up 28% and CDMO up 20%, while expanding integrated discovery partnerships and advancing peptide and ADC capabilities. Related Stocks: NSE:SAILIFE ,